Gene: Cyp11a1
Official Full Name: cytochrome P450, family 11, subfamily a, polypeptide 1provided by MGI
Gene Summary: Enables cholesterol monooxygenase (side-chain-cleaving) activity. Acts upstream of or within C21-steroid hormone biosynthetic process. Located in mitochondrion. Is expressed in several structures, including central nervous system; endocrine gland; reproductive system; retina; and skin. Human ortholog(s) of this gene implicated in congenital adrenal hyperplasia and congenital adrenal insufficiency. Orthologous to human CYP11A1 (cytochrome P450 family 11 subfamily A member 1). [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00463 | Cyp11a1 gRNA3-gRNA4 KO plasmid | Cyp11a1 | $850 | |||
KO01174 | Cyp11a1 Knockout cell line (B16-F10) | Mouse | Cyp11a1 | 1:3~1:4 | Negative | Online Inquiry |
Cyp11a1 Gene Knockout Cell Lines represent a groundbreaking advancement in genetic research, providing invaluable tools for studying steroidogenesis and the physiological roles of steroid hormones. These cell lines have been engineered to disrupt the Cyp11a1 gene, which encodes the enzyme cholesterol side-chain cleavage enzyme, a critical factor in the synthesis of steroid hormones from cholesterol. By removing the functionality of this gene, researchers can explore the resultant biochemical pathways and physiological effects, facilitating a deeper understanding of diseases linked to hormonal dysregulation.
The primary mechanism of these knockout cell lines involves the strategic inactivation of the Cyp11a1 gene through advanced gene editing techniques such as CRISPR/Cas9. This allows for the precise study of the resultant phenotypic changes concerning hormonal production, cell proliferation, and differentiation processes. Given Cyp11a1’s essential role in the steroidogenesis pathway, these cell lines are particularly useful in investigations into adrenal dysfunction, reproductive health, and metabolic disorders.
Scientifically, the applications of Cyp11a1 Gene Knockout Cell Lines extend to both basic and translational research settings. They enable researchers to model diseases associated with abnormal steroid hormone levels, examine drug interactions, and assess the implications of pharmacological agents targeting steroidogenic pathways. Their capacity to provide a controlled environment for these studies enhances the reproducibility and reliability of experimental outcomes.
Compared to traditional cell lines or animal models, Cyp11a1 knockout cell lines offer several significant advantages. They provide a more accurate representation of the genetic modifications implicated in human diseases, minimizing intersubject variability and facilitating high-throughput screening. Additionally, these cell lines can be cultured and manipulated with relative ease, allowing for a quicker turnaround in experimental design and execution.
For researchers and clinicians engaged in endocrinology, pharmacology, or metabolic research, the utility of Cyp11a1 Gene Knockout Cell Lines cannot be overstated. They provide essential insights into hormone-related mechanisms and diseases, ultimately paving the way for innovative therapeutic strategies. At [Company Name], we pride ourselves on being at the forefront of genetic research tools, offering premium biological products that empower scientific discovery and enhance research outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.